• 1. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin
• 2. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 3. Aluminium complexes with thio-phosphorus ligands: syntheses and characterisations of [Al2(CyPS3)2(CyPHS2)2] and [Al(S2PPh2)3]?
  Robert P. Davies,Maria A. Giménez,Laura Patel,Andrew J. P. White Dalton Trans., 2008, 5705-5707
• 4. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 5. Aggregation-induced emission of luminol: a novel strategy for fluorescence ratiometric detection of ALP and As(v) with high sensitivity and selectivity?
  Yuan-Jun Tong,Lu-Dan Yu,Lu-Lu Wu,Shu-Ping Cao,Ru-Ping Liang,Li Zhang,Xing-Hua Xia,Jian-Ding Qiu Chem. Commun., 2018,54, 7487-7490

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Phenylacetylindoles

Research Brief on 1-[2-(4-nitrophenyl)acetyl]-2,3-dihydro-1H-indole-2-carboxamide (CAS: 1104225-67-3)

1-[2-(4-nitrophenyl)acetyl]-2,3-dihydro-1H-indole-2-carboxamide (CAS: 1104225-67-3) is a synthetic small molecule that has recently garnered attention in the field of chemical biology and medicinal chemistry due to its potential therapeutic applications. This compound, characterized by its indole-2-carboxamide scaffold, has been investigated for its biological activity, particularly in the context of enzyme inhibition and signal transduction modulation. Recent studies have explored its role in targeting specific pathways implicated in inflammatory and neoplastic diseases, making it a promising candidate for further drug development.

The synthesis and structural characterization of 1-[2-(4-nitrophenyl)acetyl]-2,3-dihydro-1H-indole-2-carboxamide have been detailed in recent publications, highlighting its unique chemical properties. The presence of the 4-nitrophenylacetyl group and the dihydroindole moiety contributes to its ability to interact with biological targets, such as kinases and proteases. Computational docking studies have suggested that this compound exhibits high binding affinity for certain enzymes, which may underlie its observed bioactivity. These findings are supported by in vitro assays demonstrating its efficacy at micromolar concentrations.

Recent preclinical studies have focused on evaluating the pharmacological profile of 1-[2-(4-nitrophenyl)acetyl]-2,3-dihydro-1H-indole-2-carboxamide. In cellular models, the compound has shown inhibitory effects on pro-inflammatory cytokines and growth factors, suggesting potential applications in treating chronic inflammatory conditions. Additionally, its impact on cell proliferation and apoptosis has been investigated in cancer cell lines, with preliminary results indicating selective cytotoxicity against certain tumor types. These findings underscore the need for further mechanistic studies to elucidate its mode of action and optimize its therapeutic index.

Despite its promising biological activity, challenges remain in the development of 1-[2-(4-nitrophenyl)acetyl]-2,3-dihydro-1H-indole-2-carboxamide as a drug candidate. Issues such as solubility, metabolic stability, and potential off-target effects need to be addressed through structural modifications and formulation strategies. Recent efforts have explored derivatization of the core scaffold to improve pharmacokinetic properties while retaining bioactivity. Collaborative research between academic and industrial laboratories is expected to accelerate the translation of these findings into clinical applications.

In conclusion, 1-[2-(4-nitrophenyl)acetyl]-2,3-dihydro-1H-indole-2-carboxamide represents a compelling case study in the intersection of chemical synthesis and biological discovery. Its multifaceted activity profile and structural versatility make it a valuable tool for probing biological pathways and a promising lead for drug development. Future research should prioritize in vivo validation of its therapeutic potential and the development of analogs with enhanced drug-like properties. This compound exemplifies the ongoing innovation in small-molecule therapeutics within the chemical biology and pharmaceutical sectors.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)